Literature DB >> 7190083

Cyclophosphamide and cis-dichlorodiammine platinum (11). Nonempiric scheduling to spare dose-limiting tissues in the rat.

K D Tew, D M Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7190083     DOI： 10.1007/bf00254030

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  19 in total

1.  Binding of chlorozotocin and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to chromatin and nucleosomal fractions of HeLa cells.

Authors:  K D Tew; S Sudhakar; P S Schein; M E Smulson
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

2.  Recovery of normal hematopoietic tissue and tumor following chemotherapeutic injury from cyclophosphamide (CTX): comparative analysis of biochemical and clinical techniques.

Authors:  S H Rosenoff; F Bostick; R C Young
Journal:  Blood       Date:  1975-04       Impact factor: 22.113

3.  Effects of cis-dichlorodiammine platinum (II) on DNA synthesis in kidney and other tissues of normal and tumour-bearing rats.

Authors:  D M Taylor; K D Tew; J D Jones
Journal:  Eur J Cancer       Date:  1976-04       Impact factor: 9.162

4.  Acute toxicologic and pathologic effects of cis-diamminedichloroplatinum (NSC-119875) in the male rat.

Authors:  R J Kociba; S D Sleight
Journal:  Cancer Chemother Rep       Date:  1971-02

5.  Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity.

Authors:  W D DeWys; A Goldin; N El
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

6.  Prevention of renal failure in rats receiving cis-diamminedichloroplatinum(II) by administration of furosemide.

Authors:  J M Ward; M E Grabin; E Berlin; D M Young
Journal:  Cancer Res       Date:  1977-04       Impact factor: 12.701

7.  The relationship of thymidine metabolism to the use of fractional incorporation as a measure of DNA synthesis and tissue proliferation.

Authors:  K D Tew; D M Taylor
Journal:  Eur J Cancer       Date:  1978-02       Impact factor: 9.162

8.  Potentiating action of 5-fluorouracil when used in combination with platinium compounds and cyclophosphamide in treatment of advanced L1210 leukemia.

Authors:  G R Gale; L M Atkins; P Schwartz; S J Meischen
Journal:  Bioinorg Chem       Date:  1978

9.  Studies with cyclophosphamide labeled with phosphorus-32: nucleic acid alkylation and its effect on DNA synthesis in rat tumor and normal tissues.

Authors:  K D Tew; D M Taylor
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

10.  Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.

Authors:  J L Millar; B N Hudspith; N M Blackett
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.